Long-Term Prescription of α-Blockers Decrease the Risk of Recurrent Urolithiasis Needed for Surgical Intervention-A Nationwide Population-Based Study

PURPOSE: α1 receptors and subtypes have been confirmed to distribute in human pelvis and calyces recently. As used in ureteral stones, α-blocker treatment may facilitate kidney stone passage and long-term prescription of α-blocker may decrease the risk of recurrent urolithiasis. The aim of this stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Chia-Chu, Hsieh, Hui-Min, Wu, Chia-Fang, Hsieh, Tusty-Jiuan, Huang, Shu-Pin, Chou, Yii-Her, Huang, Chun-Nung, Wu, Wen-Jeng, Wu, Ming-Tsang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4395263/
https://www.ncbi.nlm.nih.gov/pubmed/25875226
http://dx.doi.org/10.1371/journal.pone.0122494

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4395263/
https://www.ncbi.nlm.nih.gov/pubmed/25875226
http://dx.doi.org/10.1371/journal.pone.0122494

Ejemplares similares